RNA MOLECULES

The present disclosure relates to RNA molecules encoding a varicella zoster virus (VZV). The present disclosure further relates to compositions comprising the RNA molecules formulated in a lipid nanoparticle (RNA-LNP). The present disclosure further relates to the use of the RNA molecules, RNA-LNPs...

Full description

Saved in:
Bibliographic Details
Main Authors JANSEN, KATHRIN UTE, MUNOZ-MORENO, RAQUEL, BENNETT, ERIC MATTHEW, SOLORZANO QUIJANO, ALICIA, DORMITZER, PHILIP RALPH, DIAZ, FERNANDO MARTIN
Format Patent
LanguageEnglish
French
Published 20.04.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to RNA molecules encoding a varicella zoster virus (VZV). The present disclosure further relates to compositions comprising the RNA molecules formulated in a lipid nanoparticle (RNA-LNP). The present disclosure further relates to the use of the RNA molecules, RNA-LNPs and compositions for the treatment or prevention of herpes zoster or shingles. La présente invention concerne des molécules d'ARN codant pour un virus varicelle-zona (VZV). La présente invention concerne en outre des compositions comprenant les molécules d'ARN formulées dans une nanoparticule lipidique (ARN-LNP). La présente invention concerne en outre l'utilisation des molécules d'ARN, des ARN-LNP et des compositions pour le traitement ou la prévention de l'herpès-zona ou du zona.
Bibliography:Application Number: CA20223235276